Malecare will be holding a free teleconference this Tuesday, April 30 at 6.m.
I will be speaking with Dr. James Gulley who is the Deputy Chief of the Laboratory of Tumor Immunology and Biology at the National Cancer Institute and the Director of the Clinical Trials Group. He also serves as a Senior Investigator within the Medical Oncology Branch of NCI.
The teleconference will review the new treatments for metastatic, castration-resistant advanced prostate cancer as well as a comprehensive conversation about the immune therapies known as cancer vaccines. We will be discussing approved and unapproved immune treatments with an expanded conversation about the investigational treatment PROSTVAC, which our speaker has been involved in both the development and testing.
We will end the teleconference by having Dr. Gulley answer some of the questions that have been sent to me.
If you are interested in listening in on the conference you can dial in at: 800-920-7486. The conference number is: 8534374. We are starting promptly at
Joel T Nowak, M.A., M.S.W.